No. 19-1061

Dr. Reddy's Laboratories, Ltd., et al. v. Eli Lilly and Company

Lower Court: Federal Circuit
Docketed: 2020-02-26
Status: Denied
Type: Paid
Amici (2) Experienced Counsel
Tags: claim-amendment doctrine-of-equivalents festo-corp-v-shoketsu festo-corp-v-shoketsu-kinzoku-kogyo-kabushiki-co patent-claim patent-infringement patent-law patent-law-doctrine-of-equivalents patent-prosecution prosecution-history-estoppel tangential-exception
Key Terms:
Patent
Latest Conference: 2020-06-11
Related Cases: 19-1058 (Vide)
Question Presented (AI Summary)

Whether patent owners may recapture subject matter they could have claimed in prosecution but did not, by arguing that they surrendered more than they needed to during prosecution to address a rejection by the Patent Office

Question Presented (OCR Extract)

QUESTION PRESENTED Under patent law’s “doctrine of equivalents,” a patent holder can allege infringement even when the defendant does not literally practice every element of a patent claim. But if the patent applicant previously narrowed the claim during prosecution to obtain the patent, the general rule for more than 100 years has been that the patent holder cannot use the doctrine of equivalents in litigation to recapture territory between the broader pre-amendment claim and the narrower post-amendment claim. That rule is known as “prosecution history estoppel.” In Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722 (2002), this Court held that prosecution history estoppel does not apply if the patentee can “show that at the time of the amendment one skilled in the art could not reasonably be expected to have drafted a claim that would have literally encompassed the alleged equivalent.” Id. at 741. A patentee can make that showing in different ways, including by demonstrating that the “the rationale underlying the amendment ... bear[s] no more than a tangential relation to the equivalent in question.” Id. at 740. The question presented is whether, under Festo’s “tangential” exception to prosecution history estoppel, patent owners may recapture subject matter they could have claimed in prosecution but did not, by arguing that they surrendered more than they needed to during prosecution to address a rejection by the Patent Office.

Docket Entries

2020-06-15
Petition DENIED.
2020-05-26
DISTRIBUTED for Conference of 6/11/2020.
2020-05-26
Reply of petitioners Dr. Reddy's Laboratories, Ltd., et al. filed. (Distributed)
2020-05-01
Motion to delay distribution of the petition for a writ certiorari until May 26, 2020, granted.
2020-04-30
Motion of petitioners to delay distribution of the petition for a writ of certiorari under Rule 15.5 from May 12, 2020 to May 26, 2020, submitted to The Clerk.
2020-03-27
Brief amicus curiae of Association for Accessible Medicines filed.
2020-03-26
Brief amicus curiae of America's Health Insurance Plans filed.
2020-03-11
Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2020.
2020-03-10
Motion to extend the time to file a response from March 27, 2020 to April 27, 2020, submitted to The Clerk.
2020-02-24
Petition for a writ of certiorari filed. (Response due March 27, 2020)
2020-01-24
Application (19A818) granted by The Chief Justice extending the time to file until February 24, 2020.
2020-01-22
Application (19A818) to extend the time to file a petition for a writ of certiorari from February 6, 2020 to February 24, 2020, submitted to The Chief Justice.

Attorneys

America's Health Insurance Plans
Anna-Rose MathiesonCalifornia Appellate Law Group LLP, Amicus
Anna-Rose MathiesonCalifornia Appellate Law Group LLP, Amicus
Association for Accessible Medicines
Brian Timothy BurgessGoodwin Procter, LLP, Amicus
Brian Timothy BurgessGoodwin Procter, LLP, Amicus
Dr. Reddy's Laboratories, Ltd., et al.
John Caviness O'QuinnKirkland & Ellis LLP, Petitioner
John Caviness O'QuinnKirkland & Ellis LLP, Petitioner
Eli Lilly & Company
Adam Lawrence PerlmanLatham& Watkins LLP, Respondent
Adam Lawrence PerlmanLatham& Watkins LLP, Respondent
R Street Institute
Charles DuanR Street Institute, Amicus
Charles DuanR Street Institute, Amicus